CAPR: Capricor Therapeutics Inc
CAPR exchange rate has changed by -3.83% for today. During the day, the instrument was traded at a low of 26.30 and at a high of 27.62.
Follow Capricor Therapeutics Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
CAPR News
- MAHA Is Bringing Chaos to Biotech Investment Beyond Just Vaccines
- Oppenheimer reiterates Outperform rating on Capricor stock, maintains $54 target
- CAPR Updates FDA on Deramiocel BLA, Plans HOPE-3 CSR Filing in February
- Capricor to submit HOPE-3 data to FDA for DMD therapy review
- Capricor Therapeutics stock rating reiterated by Cantor Fitzgerald
- Cantor Fitzgerald reiterates Overweight rating on Capricor stock
- Capricor Therapeutics Stock: A High Risk/High Reward Name (NASDAQ:CAPR)
- Biotech Stocks' Dark Winter Is Over. What That Means For Investors.
- Capricor Therapeutics, Inc. (CAPR) Discusses HOPE-3 Phase III Trial Results and Regulatory Path for Duchenne Muscular Dystrophy Therapy Transcript
- Piper Sandler reiterates Capricor stock rating, names it 2026 top pick
- PPMD to host webinar on Capricor’s DMD therapy trial results
- Piper Sandler raises Capricor Therapeutics stock price target to $45 on trial success
- Oppenheimer raises Capricor Therapeutics price target to $54 on positive trial data
- Martin Shkreli's Biotech Short Position Is Blowing Up As Stock Soars 440%: Momentum Score Spikes - Capricor Therapeutics (NASDAQ:CAPR)
- Capricor: 'Hold' Rating On Randomized Phase 3 HOPE-3 Trial Win With Deramiocel (CAPR)
- Capricor Therapeutics, Inc. (CAPR) Discusses HOPE-3 Phase III Top Line Data for Deramiocel in Duchenne Muscular Dystrophy Transcript
- CAPR Stock Skyrockets 282% in a Week: Here's What You Need to Know
- Capricor Therapeutics prices public offering at $25 per share
Frequently Asked Questions
What is CAPR stock price today?
Capricor Therapeutics Inc stock is priced at 26.86 today. It trades within 26.30 - 27.62, yesterday's close was 27.93, and trading volume reached 1579. The live price chart of CAPR shows these updates.
Does Capricor Therapeutics Inc stock pay dividends?
Capricor Therapeutics Inc is currently valued at 26.86. Dividend policy depends on the company, while investors also watch 180.38% and USD. View the chart live to track CAPR movements.
How to buy CAPR stock?
You can buy Capricor Therapeutics Inc shares at the current price of 26.86. Orders are usually placed near 26.86 or 27.16, while 1579 and 0.64% show market activity. Follow CAPR updates on the live chart today.
How to invest into CAPR stock?
Investing in Capricor Therapeutics Inc involves considering the yearly range 4.30 - 40.37 and current price 26.86. Many compare 0.64% and 272.54% before placing orders at 26.86 or 27.16. Explore the CAPR price chart live with daily changes.
What are Capricor Therapeutics Inc stock highest prices?
The highest price of Capricor Therapeutics Inc in the past year was 40.37. Within 4.30 - 40.37, the stock fluctuated notably, and comparing with 27.93 helps spot resistance levels. Track Capricor Therapeutics Inc performance using the live chart.
What are Capricor Therapeutics Inc stock lowest prices?
The lowest price of Capricor Therapeutics Inc (CAPR) over the year was 4.30. Comparing it with the current 26.86 and 4.30 - 40.37 shows potential long-term entry points. Watch CAPR moves on the chart live for more details.
When did CAPR stock split?
Capricor Therapeutics Inc has gone through stock splits historically. These changes are visible in , 27.93, and 180.38% after corporate actions.
- Previous Close
- 27.93
- Open
- 26.69
- Bid
- 26.86
- Ask
- 27.16
- Low
- 26.30
- High
- 27.62
- Volume
- 1.579 K
- Daily Change
- -3.83%
- Month Change
- 0.64%
- 6 Months Change
- 272.54%
- Year Change
- 180.38%